Goldman Sachs is warning of a possible stock market correction, thanks to high risk-appetite and enthusiastic retail ...

Goldman Sachs posted strong Q2 results, raised dividends 33%, and sees AI-driven growth ahead, despite valuation risks after ...

Goldman Sachs reported its best-ever quarter for stock trading. Wall Street banks have posted mostly strong results for the ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Nebius stock rallies as Goldman Sachs issues a bullish note in its favor. Analyst Alex Duval expects NBIS shares to hit $68 ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of Goldman Sachs’ top healthcare stock picks. On July 1, the ...

Goldman Sachs is scheduled to report second-quarter results on Wednesday morning, with traders expecting a move that could ...

Nebius stock has soared impressively this year, and its rise seems justified considering its outstanding growth and solid ...

Goldman Sachs posted the largest quarterly stock-trading bonanza in its history, as banks across Wall Street bagged fat ...

I maintain a buy rating on XLG, as rate cuts and economic stability should fuel further gains in large-cap tech stocks.

Goldman Sachs (NYSE: GS) reported a solid second quarter with earnings beating estimates and strong performance in trading ...

Following our analysis of the options activities associated with Goldman Sachs Group, we pivot to a closer look at the company's own performance. With a volume of 203,430, the price of GS is down ...